On May 10, 2021, CTI Capital announced its new venture capital fund. The new fund includes cash from the Fonds de solidarité FTQ, Caisse de dépôt et placement du Québec (CDPQ), Investissement Québec (IQ) and Teralys Capital. CTI Capital will use this fund to invest in biotherapeutics, medial technologies and healthcare IT.
CTI Capital is a Montreal-based private venture capital fund investing in high quality emerging life science companies.
Osler, Hoskin & Harcourt LLP advised CTI Capital with a team consisting of Chima Ubani, Liliana Korosi (Emerging & High Growth Companies), and Bradley Sendel (Corporate).